Welcome to G-FINDER

The G-FINDER survey tracks global public, private, and philanthropic investment into product research and development for neglected diseases. These are diseases that predominantly affect developing countries and for which products are needed but there is insufficient commercial pull to stimulate R&D.

The survey includes R&D of drugs, vaccines, diagnostics, insecticides, microbicides and other pharmaceutical tools, from basic research through to post-registration studies. For more information, please refer to the frequently asked questions.

The project is conducted by Policy Cures and funded by the Bill & Melinda Gates Foundation.


G-FINDER Reports


Survey results are published as yearly reports. The first eight reports are available here:

G-FINDER 2008. Neglected Disease Research & Development: How much are we really spending?

G-FINDER 2009. Neglected Disease Research & Development: New times, new trends.

G-FINDER 2010. Neglected Disease Research & Development: Is the global financial crisis changing R&D

G-FINDER 2011. Neglected Disease Research & Development: Is innovation under threat?

G-FINDER 2012. Neglected Disease Research & Development: A five year review

G-FINDER 2013. Neglected Disease Research & Development: The public divide

G-FINDER 2014. Neglected Disease Research & Development: Emerging trends

G-FINDER 2015. Neglected Disease Research & Development: The Ebola Effect


The underlying data behind the G-FINDER reports is also made freely available via the G-FINDER public search facility (with confidential industry data aggregated and anonymised): click here to search the G-FINDER data


Key dates


29 July 2016
Deadline for completing the survey

SURVEY OPEN

December 2016

    Publication and global launch of       the ninth annual report


0 days left to complete the survey.

SURVEY OPEN